Kevin Castille (M)

athlete, from United States of America, born 1972-03-17, 1 sanction

Notes: Colorado Springs, Colo. (July 16, 2020) USADA announced today that Kevin Castille, of Baton Rouge, La., an athlete in the sport of track and field, has accepted a four-year suspension for an anti-doping rule violation. Castille, 48, tested positive for 19-norandrosterone (19-NA), the main urinary metabolite of nandrolone (19-nortestosterone) and other 19-norsteroids, as a result of an in-competition drug test conducted at the USA Track & Field Masters 10K Championship on April 28, 2019, at which Castille finished first. The presence of 19-NA was confirmed in his urine sample using a specialized test that differentiates between anabolic androgenic steroids (AAS), which are produced naturally by the body, and prohibited anabolic agents of external origin. Anabolic agents have powerful performance-enhancing capabilities and can give an athlete an unfair advantage over fellow competitors.

2019 - 19-norandrosterone (19-NA), the main urinary metabolite of nandrolone (19-nortestosterone) and other 19-norsteroids


Start
Date

April 28, 2019

3 years, 9 months finished

End
Date

April 27, 2023


Status

no record

Date of Infraction

April 28, 2019

Event

USA Track & Field Masters 10K Championship on April 28, 2019 (10K road race)